Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.

Crystallization and solid form challenges in pharmaceutical intermediates shown through laboratory crystal analysis

Crystallization & Solid Form Challenges for Intermediates

Crystallization and solid-form control are critical to intermediate quality, scalability, and downstream API performance. This article explores common solid-state challenges, scale-up risks, and why early ...

Orforglipron oral GLP-1 weight loss drug with molecular structure and pharmaceutical tablets on blue background

Orforglipron: A New Oral GLP-1 Option Redefining Weight Management

Orforglipron is Eli Lilly’s oral GLP-1 receptor agonist for weight management, currently under FDA review. This article examines its clinical background, weight-maintenance data, and implications ...

Laboratory and manufacturing scenes illustrating batch-to-batch consistency in pharmaceutical intermediate production

Batch-to-Batch Consistency: Why It Matters for Intermediates

Learn why batch-to-batch consistency is critical for pharmaceutical intermediates, impacting impurity control, scale-up success, and regulatory compliance.

Laboratory and manufacturing view illustrating technical challenges and quality requirements for oncology intermediates production.

Oncology Intermediates: Technical Challenges & Quality Expectations

This article examines the core technical challenges faced during oncology intermediate manufacturing, including reaction selectivity control, impurity structural fixation, and scale-up consistency risks.

Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.

Quick Links

Contact us